Cargando…
Survival of COVID-19 with Multimorbidity Patients
Background: The outbreak of SARS-CoV-2 abruptly disseminated in early 2020, overcoming the capacity of health systems to respond the pandemic. It was not until the vaccines were launched worldwide that an increase in survival was observed. The objectives of this study were to analyse the characteris...
Autores principales: | Bustos-Vázquez, E., Padilla-González, E., Reyes-Gómez, D., Carmona-Ramos, M. C., Monroy-Vargas, J. A., Benítez-Herrera, A. E., Meléndez-Mier, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617866/ https://www.ncbi.nlm.nih.gov/pubmed/34828470 http://dx.doi.org/10.3390/healthcare9111423 |
Ejemplares similares
-
Use of Fluoxetine to Reduce Weight in Adults with Overweight or Obesity: Abridged Republication of the Cochrane Systematic Review
por: Serralde-Zuñiga, Aurora E., et al.
Publicado: (2022) -
Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database
por: Carmona-Pírez, Jonás, et al.
Publicado: (2022) -
THE CLINICAL-EVOLUTIVE SPECTRUM OF COVID-19 IN A GERIATRIC, MULTIMORBID POPULATION
por: CÎRJALIU, R.-E., et al.
Publicado: (2022) -
Multimorbidity patterns among COVID-19 deaths: proposal for the construction of etiological models
por: Fernández-Niño, Julián A., et al.
Publicado: (2020) -
Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)